The market’s first-half rally in 2025 left some major names behind. While the S&P 500 gained 5.5% through June, several prominent companies saw their stock prices plunge. These are not fading startups or hollow growth stories. They are established firms that hit temporary setbacks, saw valuation pressure mount, and now trade at levels that may attract bargain hunters. Below are four resurrection stocks with the potential to recover in the second half of the year.
4 Resurrection Stocks That Can Come Back from the Dead in 2025
Each of these companies lost 30% or more in the first half of the year. But their sharp declines don’t stem from crumbling business models or evaporating demand. Instead, they reflect temporary setbacks such as regulatory overhang, margin pressure, or market overreaction. For investors willing to look past near‑term volatility, these names offer a shot at redemption by year‑end.
UnitedHealth (UNH, NYSE)
UnitedHealth Group is the nation’s largest health insurance provider and a key player in managed care. Its stock fell 38% through the first half of 2025 as rising medical costs and political pressure on healthcare programs spooked investors. The company also withdrew its full‑year guidance, adding to the uncertainty.
UnitedHealth now trades at $311.60 as of July 9, up slightly from its late‑June lows. The company’s market cap stands at approximately $282 billion, still far below the $500 billion level it held in 2024. With a trailing price‑to‑earnings ratio of just 13, the stock is priced well below the S&P 500 average of 24. Despite near‑term headwinds, the business remains profitable and continues to target long‑term annual growth of 13% to 16%. A modest earnings beat or easing of regulatory pressure could drive a recovery in the coming months.
Marvell Technology (MRVL, NASDAQ)
Marvell Technology designs custom semiconductors, including ASICs for hyperscale data centers and AI applications. The stock dropped 30% in the first six months of the year after its forward guidance disappointed investors expecting faster AI‑driven revenue gains.
As of July 9, Marvell shares trade at $72.90. The company reported $1.9 billion in revenue for the quarter ending May 3, a 63% increase from the previous year. Despite that performance, the market trimmed expectations, and Marvell’s forward price‑to‑earnings ratio now sits around 27. That puts it below the average for other AI chipmakers, offering a potentially attractive entry point. The company’s strong order pipeline, especially for AI infrastructure, may help reverse sentiment and lift the stock.
Deckers Outdoor (DECK, NYSE)
Deckers Outdoor is an apparel and footwear company known for brands like HOKA and UGG. Shares collapsed by 49% through June, weighed down by consumer slowdown fears and exposure to China‑related tariff risks.
Yet Deckers continues to post healthy financials. The stock now trades at $106.40. In the quarter ending March 31, the company reported $1.05 billion in revenue and $151 million in net income, marking 6% and 19% year‑over‑year gains, respectively. Its current price‑to‑earnings ratio is just 17. If discretionary spending holds and trade pressures stabilize, the stock could see a sharp recovery from its deeply discounted levels.
Rivian (RIVN, NASDAQ)
Rivian is an electric vehicle manufacturer backed by major investors and known for its R1T pickup, R1S SUV, and delivery vans built for Amazon. Its stock is down 44% this year amid weak sentiment in the EV sector and the recent loss of federal EV tax credits starting this July.
As of July 9, Rivian trades at $12.32. The company ended Q1 with over $7 billion in liquidity. Deliveries rose 45% year‑over‑year in Q2, and management reaffirmed production targets. Still, high cash burn and the loss of key subsidies make the road ahead difficult. If Rivian executes well in the second half and narrows its losses, a reversal is possible, especially if EV sentiment improves.
Why These Resurrection Stocks May Ignite a Late‑Year Recovery
Each of these stocks dropped for clear reasons: valuation compression, regulatory risk, or sector‑wide pessimism. But the fundamentals in all four cases remain intact. If inflation continues to ease and business performance stabilizes, investors may reassess the risk‑reward tradeoff. For contrarians, these names offer an opportunity to buy quality companies while sentiment remains low.
Which of these resurrection stocks looks most likely to rally by December? Tell us what you think.
Survey